In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.
Click here for podcast
Click here for related whitepaper
All PharmaVOICE podcasts
